NeuroDex

Private

Natick, MassachusettsHealthcare & Life Scienceshttps://neurodex.co/

Last Round

Grant

Nov 6, 2024

Total Funding Raised

$1.55M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

NeuroDex is a biotechnology company that has developed a blood-based diagnostics platform designed to diagnose neurodegenerative diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Government Contracts

AI Layer

Non-AI

Keywords

biomarker discoveryexosome isolationneurodiagnosticsliquid biopsyclinical trial servicesneurodegenerative diseasesneuron-derived exosomesblood-based testingdrug development supportdiagnostics platformpatient stratificationAlzheimer's diseaseParkinson's diseasebiomarker panelspreclinical services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeuroDex Comps

Public and private peers based on sector, stage, and business model.

NeuroDex comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NeuroDex Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Nov 6, 2024
Grant	Nov 1, 2024
Grant	Oct 31, 2023
Grant	Mar 28, 2023
Grant	Jan 26, 2023
Seed	Aug 16, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Victoria Akhiezer

COO

Executive Team

NeuroDex Investors

Notable investors and investment history

NeuroDex investors
Investor	Rounds
Target ALS	Grant
The Michael J. Fox Foundation for Parkinson's Research	Grant
ICV Venture Engineering Fund I	Seed
Alzheimer's Drug Discovery Foundation	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 22, 2026
Monthly visitors increased 251% MoM.
Aug 25, 2025
Grew 23% QoQ, from 13 to 16 employees.

View all signals

NeuroDex Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

NeuroDex Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NeuroDex's valuation, stock price, and market status.

Firmographic Details

HeadquartersNatick, Massachusetts

Employee Range15

Year Founded2018

Last FundingNov 6, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.